Artículos por temáticas

Cerium Oxide Nanoparticles Rescue α-Synuclein-Induced Toxicity in a Yeast Model of Parkinson's Disease

Ruotolo R, De Giorgio G, Minato I, Bianchi MG, Bussolati O, Marmiroli N.

Nanomaterials (Basel). 2020 Jan 29;10(2):235. doi: 10.3390/nano10020235.

Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant?

Bisaglia M, Bubacco L.

Biomolecules. 2020 Jan 29;10(2):195. doi: 10.3390/biom10020195.

Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease

Vallée A, Lecarpentier Y, Guillevin R, Vallée JN.

Cells. 2020 Jan 28;9(2):314. doi: 10.3390/cells9020314.

Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease

Teixeira FG, Vilaça-Faria H, Domingues AV, Campos J, Salgado AJ.

Cells. 2020 Jan 28;9(2):315. doi: 10.3390/cells9020315.

Beneficial Effect of Foot Plantar Stimulation in Gait Parameters in Individuals with Parkinson's Disease

Brognara L, Navarro-Flores E, Iachemet L, Serra-Catalá N, Cauli O.

Brain Sci. 2020 Jan 27;10(2):69. doi: 10.3390/brainsci10020069.

The Potential Role of Astrocytes in Parkinson's Disease (PD)

Hindeya Gebreyesus H, Gebrehiwot Gebremichael T.

Med Sci (Basel). 2020 Jan 27;8(1):7. doi: 10.3390/medsci8010007.

Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's Disease

Deng X, Xiao B, Li HH, Ng E, Lo YL, Tan EK, Prakash KM.

Front Neurol. 2020 Jan 17;10:1379. doi: 10.3389/fneur.2019.01379. eCollection 2019.

Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson's Disease

Chambers NE, Lanza K, Bishop C.

Front Pharmacol. 2020 Jan 15;10:1494. doi: 10.3389/fphar.2019.01494. eCollection 2019.

Ca(V)1.3 L-Type Calcium Channels Increase the Vulnerability of Substantia Nigra Dopaminergic Neurons in MPTP Mouse Model of Parkinson's Disease

Verma A, Ravindranath V.

Front Aging Neurosci. 2020 Jan 17;11:382. doi: 10.3389/fnagi.2019.00382. eCollection 2019.

Modeling Cell-Cell Interactions in Parkinson's Disease Using Human Stem Cell-Based Models

Simmnacher K, Lanfer J, Rizo T, Kaindl J, Winner B.

Front Cell Neurosci. 2020 Jan 17;13:571. doi: 10.3389/fncel.2019.00571. eCollection 2019.

Specialist palliative care for Parkinson's disease

Oliver D, Veronese S.

Ann Palliat Med. 2020 Feb;9(Suppl 1):S52-S62. doi: 10.21037/apm.2019.12.01. Epub 2020 Jan 24.

[The diagnostic value of tremor analysis for defining the Parkinson's disease subtype]

Liu XX, Zhang S, Liu N, Sun AP, Zhang YS, Fan DS.

Zhonghua Yi Xue Za Zhi. 2020 Jan 21;100(3):207-212. doi: 10.3760/cma.j.issn.0376-2491.2020.03.010.

An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson's Disease and G2019S LRRK2 Cohorts

Padmanabhan S, Lanz TA, Gorman D, Wolfe M, Joyce A, Cabrera C, Lawrence-Henderson R, Levers N, Joshi N, Ma TC, Liong C, Narayan S, Alcalay RN, Hutten SJ, Baptista MAS, Merchant K.

J Parkinsons Dis. 2020;10(2):623-629. doi: 10.3233/JPD-191786.

Altered Transcriptional Profile of Mitochondrial DNA-Encoded OXPHOS Subunits, Mitochondria Quality Control Genes, and Intracellular ATP Levels in Blood Samples of Patients with Parkinson's Disease

Gezen-Ak D, Alaylıoğlu M, Genç G, Şengül B, Keskin E, Sordu P, Güleç ZEK, Apaydın H, Bayram-Gürel Ç, Ulutin T, Yılmazer S, Ertan S, Dursun E.

J Alzheimers Dis. 2020;74(1):287-307. doi: 10.3233/JAD-191164.

Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease

Wijeyekoon RS, Kronenberg-Versteeg D, Scott KM, Hayat S, Kuan WL, Evans JR, Breen DP, Cummins G, Jones JL, Clatworthy MR, Floto RA, Barker RA, Williams-Gray CH.

Brain Behav Immun. 2020 Jul;87:473-488. doi: 10.1016/j.bbi.2020.01.018. Epub 2020 Jan 30.